U.S. MARKETS FOR DIAGNOSTIC ONCOLOGY-RELATED X-RAY-BASED IMAGING PRODUCTS

235 Pages | 47 Exhibits | 2013 Analysis | Forecasts Through 2017 Product Family: Market Reports




OVERVIEW:
Cancer is the second-leading cause of death in the United States (U.S.) after heart disease. It is estimated that nearly 1.7 million people in the country will be diagnosed with cancer in 2013, and that approximately 580,350 will die from the disease. In the fight against cancer, X-ray-based imaging modalities allow physicians to detect malignancies at their earliest and most treatable stages.

In 2012, approximately 279.4 million diagnostic oncology-related X-ray-based imaging procedures-including conventional X-ray, computed tomography (CT), and mammography-were performed in the U.S. Together, these procedures (performed with and without contrast agents) generated nearly $3.3 billion in corresponding product sales. It is expected that during the forecast period covered by this report, sales of X-ray-based imaging products for diagnostic oncology indications will increase at a compound annual rate of 3.5%, reaching more than $3.9 billion in the year 2017.

This dynamic, new report from Medtech Insight includes analyses of products, current and forecast markets, competitors, and opportunities in the U.S. diagnostic oncology-related X-ray-based imaging products arena.

Covered topics in this report include an overview of cancer in the U.S. including discussions on the different forms of the disease, risk factors for disease development, disease diagnosis, and statistics covering new cancer cases, cancer prevalence, and deaths due to cancer; computer-aided detection; conventional X-ray-based imaging detectors and systems, and procedure and sales volumes; CT detectors and systems, and procedure and sales volumes; digital versus screen-film devices for X-ray detection and image preservation; mammography systems, and procedure and sales volumes; oncology-related X-ray-based imaging contrast agents, procedure and sales volumes, and tomosynthesis for breast and chest imaging applications; among others.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. New Cancer Cases, Cancer Prevalence, and Deaths Due to Cancer 
ii. Diagnostic Oncology-Related X-Ray-Based Imaging Procedures 
iii. Diagnostic Oncology-Related X-Ray-Based Imaging Products 
	a. Conventional X-Ray-Based Imaging Systems 
		i. Market Forecast 
	b. Mammography Systems 
		i. Market Forecast 
	c. Computed Tomography Systems 
		i. Market Forecast 
	d. Contrast Media for X-Ray-Based Imaging 
		i. Market Forecast 
iv. Methodology 

Exhibit ES-1: Estimated New Cases, Prevalence, and Deaths for Selected Types of Cancer 
Exhibit ES-2: X-Ray-Based Imaging, Combined Procedure Volumes  Forecast, 2012-2017 
Exhibit ES-3: Diagnostic Oncology-Related X-Ray-Based Imaging,  Combined Procedure Volumes Forecast, 2012-2017 
Exhibit ES-4: X-Ray-Based Imaging Systems, Combined Market Forecast,  2012-2017 
Exhibit ES-5: Diagnostic Oncology-Related X-Ray-Based Imaging Products, Combined Market Forecast,  2012-2017 
Exhibit ES-6: Conventional X-Ray-Based Imaging Systems,  Market Forecast, 2012-2017 
Exhibit ES-7: Mammography Systems, Market Forecast, 2012-2017 
Exhibit ES-8: Computed Tomography Systems, Market Forecast, 2012-2017 
Exhibit ES-9: Oncology-Related X-Ray-Based Imaging Contrast Agents,  Market Forecast, 2012-2017 

1. CANCER STATISTICS UPDATE

1.1 Acquired Capabilities of Cancer Cells 
1.2 Cataloging Genomic Alterations Involved in the Development of Cancer 
1.3 Risk Factors Associated with the Development of Cancer 
1.4 Cancer Staging 
1.5 New Cancer Cases, Cancer Prevalence, and Deaths Due to Cancer 
1.6 Clinical and Statistical Data for Selected Types of Cancer 
	1.6.1 Brain and Other Nervous System Cancers 
		1.6.1.1 Etiology 
		1.6.1.2 Epidemiology 
	1.6.2 Breast Cancer 
		1.6.2.1 Etiology 
		1.6.2.2 Epidemiology 
	1.6.3 Colorectal Cancer 
		1.6.3.1 Etiology 
		1.6.3.2 Epidemiology 
	1.6.4 Kidney/Renal Pelvis Cancer 
		1.6.4.1 Etiology 
		1.6.4.2 Epidemiology 
	1.6.5 Leukemia 
		1.6.5.1 Etiology 
		1.6.5.2 Epidemiology 
	1.6.6 Lung/Bronchus Cancer 
		1.6.6.1 Etiology 
		1.6.6.2 Epidemiology 
	1.6.7 Lymphoma 
		1.6.7.1 Etiology 
		1.6.7.2 Epidemiology 
	1.6.8 Melanoma 
		1.6.8.1 Etiology 
		1.6.8.2 Epidemiology 
	1.6.9 Oral Cavity and Pharyngeal Cancers 
		1.6.9.1 Etiology 
		1.6.9.2 Epidemiology 
	1.6.10 Ovarian Cancer 
		1.6.10.1 Etiology 
		1.6.10.2 Epidemiology 
	1.6.11 Pancreatic Cancer 
		1.6.11.1 Etiology 
		1.6.11.2 Epidemiology 
	1.6.12 Prostate Cancer 
		1.6.12.1 Etiology 
		1.6.12.2 Epidemiology 
	1.6.13 Thyroid Cancer 
		1.6.13.1 Etiology 
		1.6.13.2 Epidemiology 
	1.6.14 Urinary Bladder Cancer 
		1.6.14.1 Etiology 
		1.6.14.2 Epidemiology 
	1.6.15 Uterine Cancer 
		1.6.15.1 Etiology 
		1.6.15.2 Epidemiology 

Exhibit 1-1: Estimated New Cases, Prevalence, and Deaths for Selected  Types of Cancer 
Exhibit 1-2: Brain and Other Nervous System Cancers, Facts And Figures 
Exhibit 1-3: Breast Cancer, Facts And Figures 
Exhibit 1-4: Colorectal Cancer, Facts And Figures 
Exhibit 1-5: Kidney/Renal Pelvis Cancers, Facts And Figures 
Exhibit 1-6: Leukemia, Facts and Figures 
Exhibit 1-7: Lung/Bronchus Cancer, Facts And Figures 
Exhibit 1-8: Hodgkin Lymphoma, Facts and Figures 
Exhibit 1-9: Non-Hodgkin Lymphoma, Facts and Figures 
Exhibit 1-10: Melanoma, Facts and Figures 
Exhibit 1-11: Oral Cavity and Pharyngeal Cancers, Facts and Figures 
Exhibit 1-12: Ovarian Cancer, Facts and Figures 
Exhibit 1-13: Pancreatic Cancer, Fact and Figures 
Exhibit 1-14: Prostate Cancer, Facts And Figures 
Exhibit 1-15: Thyroid Cancer, Fact and Figures 
Exhibit 1-16: Urinary Bladder Cancer, Fact and Figures 
Exhibit 1-17: Cancer of the Uterine Corpus, Facts and Figures 
Exhibit 1-18: Cancer of the Uterine Cervix, Facts and Figures 

2. U.S. MARKETS FOR DIAGNOSTIC ONCOLOGY-RELATED  X-RAY-BASED IMAGING PRODUCTS

2.1 Conventional X-Ray-Based Imaging Systems, Market Analysis 
	2.1.1 Technologies 
	2.1.2 Procedure Volumes
	2.1.3 Products 
	2.1.4 Market Forecast 
	2.1.5 Competitive Analysis 
2.2 Mammography Systems, Market Analysis
	2.2.1 Technologies 
	2.2.2 Procedure Volumes 
	2.2.3 Products 
	2.2.4 Market Forecast 
	2.2.5 Competitive Analysis 
2.3 Computed Tomography Systems, Market Analysis 
	2.3.1 Technologies 
	2.3.2 Procedure Volumes 
	2.3.3 Products 
	2.3.4 Market Forecast 
	2.3.5 Competitive Analysis 
2.4 Contrast Media for X-Ray-Based Imaging, Market Analysis 
	2.4.1 Types of Contrast Media 
	2.4.2 Procedure Volumes 
	2.4.3 Products 
	2.4.4 Market Forecast 
	2.4.5 Competitive Analysis 

Exhibit 2-1: X-Ray-Based Imaging, Combined Procedure Volumes  Forecast, 2012-2017 
Exhibit 2-2: Diagnostic Oncology-Related X-Ray-Based Imaging,  Combined Procedure Volumes Forecast, 2012-2017 
Exhibit 2-3: X-Ray-Based Imaging Systems, Combined Market Forecast, 2012-2017 
Exhibit 2-4: Diagnostic Oncology-Related X-Ray-Based Imaging Products, Combined Market Forecast, 2012-2017 
Exhibit 2-5: Conventional X-Ray-Based Imaging, Procedure Volumes Forecast, 2012-2017 
Exhibit 2-6: 2013, Selected Conventional X-Ray-Based Imaging Systems 
Exhibit 2-7: Conventional X-Ray-Based Imaging Systems, Market Forecast, 2012-2017 
Exhibit 2-8: 2012, Conventional X-Ray-Based Imaging Systems Market,  Share by Supplier 
Exhibit 2-9: Mammography, Procedure Volumes Forecast, 2012-2017 
Exhibit 2-10: 2013, Selected Mammography Systems 
Exhibit 2-11: Digital Mammography Systems, Installed Base, 2004-2012 
Exhibit 2-12: Mammography Systems, Market Forecast, 2012-2017 
Exhibit 2-13: 2012, Mammography Systems Market, Share by Supplier 
Exhibit 2-14: Computed Tomography, Procedure Volumes Forecast, 2012-2017 
Exhibit 2-15: 2013, Selected Computed Tomography Systems 
Exhibit 2-16: Computed Tomography Systems, Market Forecast, 2012-2017 
Exhibit 2-17: 2012, Computed Tomography Systems Market,  Share by Supplier 
Exhibit 2-18: Contrast-Enhanced Oncology-Related X-Ray-Based Imaging, Procedure Volumes Forecast, 2012-2017 
Exhibit 2-19: Oncology-Related X-Ray-Based Imaging Contrast Agents,  Market Forecast, 2012-2017 
Exhibit 2-20: 2012, Oncology-Related X-Ray-Based Imaging Contrast Agents Market, Share by Supplier 

3. COMPANY PROFILES

3.1 Bayer HealthCare Pharmaceuticals, Inc./Bayer HealthCare LLC/Bayer AG 
3.2 Bracco Diagnostics, Inc./Bracco Imaging SPA/Bracco SPA/Bracco 
3.3 Carestream Health, Inc./Onex Corporation 
3.4 Fujifilm Medical Systems USA, Inc./Fujifilm Holdings America Corporation/Fujifilm 
3.5 GE Healthcare, Inc./General Electric Company 
3.6 Hitachi Medical Systems America, Inc./Hitachi Medical Corporation/Hitachi LTD 
3.7 Hologic, Inc. 
3.8 KUB Technologies, Inc. 
3.9 Mallinckrodt, Inc./Covidien LTD 
3.10 Philips Healthcare, Inc./Royal Philips Electronics NV 
3.11 Samsung Electronics America, Inc./Samsung Electronics Co., LTD/Samsung 
3.12 Shimadzu Medical Systems, Inc./Shimadzu Corporation 
3.13 Siemens Healthcare/Siemens Medical Solutions USA, Inc./Siemens AG 
3.14 Toshiba America Medical Systems, Inc./Toshiba Corporation 

APPENDIX:  COMPANY LISTING 


COMPANIES COVERED:

  1. Agfa HealthCare/Agfa-Gevaert Group
  2. Analogic Corporation
  3. Bayer HealthCare Pharmaceuticals, Inc./Bayer HealthCare LLC/ Bayer AG
  4. Bioniche Pharma, Inc./Mylan, Inc.
  5. Bracco Diagnostics, Inc./Bracco Imaging SPA/ Bracco SPA/ Bracco
  6. Canon U.S.A., Inc./Canon Group
  7. Carestream Health, Inc./Onex Corporation
  8. Del Medical, Inc./UMG, Inc.
  9. Dexela LTD/PerkinElmer, Inc.
  10. Dunlee, Inc./Philips Healthcare Royal Philips Electronics NV
  11. EDDA Technology, Inc.
  12. Fujifilm Medical Systems U.S.A., Inc./Fujifilm Holdings America Corporation/Fujifilm
  13. GE Healthcare, Inc./ General Electric Company
  14. Giotto USA/Internazionale Medico Scientifica SRL
  15. Guerbet LLC/Guerbet Group
  16. Hitachi Medical Systems America, Inc./Hitachi Medical Corporation/Hitachi LTD
  17. Hologic, Inc.
  18. iCAD, Inc.
  19. IMIX Holding AB
  20. Konica Minolta Medical Imaging U.S.A., Inc./Konica Minolta Holdings, Inc.
  21. KUB Technologies, Inc.
  22. Mallinckrodt, Inc./Covidien LTD
  23. MinXray, Inc.
  24. NeuroLogica/Samsung Electronics America, Inc./Samsung Electronics Co., LTD/Samsung
  25. Neusoft Medical Systems U.S.A./Neusoft Medical Systems Co., LTD Neusoft Corporation
  26. Philips Healthcare/oyal Philips Electronics NV
  27. Planmed USA/Planmed OY/lanmeca
  28. Quantum Medical Imaging/arestream Health, Inc./Onex Corporation
  29. Riverain Technologies LLC
  30. Samsung Medison/Samsung Electronics America, Inc./Samsung Electronics Co., LTD/Samsung
  31. Sectra North America, Inc./Sectra Medical Systems AB/Sectra AB
  32. Shimadzu Medical Systems/Shimadzu Corporation
  33. Siemens Healthcare/Siemens Medical Solutions USA, Inc. Siemens AG
  34. Swissray International, Inc.
  35. Teledyne DALSA Inc./Teledyne Technologies, Inc.
  36. Toshiba America Medical Systems, Inc./Toshiba Corporation
  37. Trixell SAS
  38. Varian Medical Systems, Inc.
  39. VuCOMP, Inc.
Contact Us

Need help finding medtech research? Let us help you!